---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/100000000977589.md"
description: "📢 𝐉𝐔𝐒𝐓 𝐈𝐍: $ImmunityBio(IBRX.US) ImmunityBio Reports Label Expansion and Additional Global Approval with Q3 2026 Net Product Revenue of $48.7 Million, Up 53% Year-Over-Year and First Nine Months U.S. Revenue Up 92% to $143.6 Million"
datetime: "2026-11-09T12:35:11.000Z"
locales:
  - [en](https://longbridge.com/en/topics/100000000977589.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/100000000977589.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/100000000977589.md)
author: "[Hardik Shah](https://longbridge.com/en/profiles/27423834.md)"
generator: "portal-rs"
---

# 📢 𝐉𝐔𝐒𝐓 𝐈𝐍: $ImmunityBio(IBRX.US) ImmunityBio Repor…


### Related Stocks

- [IBRX.US](https://longbridge.com/en/quote/IBRX.US.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**